130 related articles for article (PubMed ID: 6490136)
1. Effects of high-dose methotrexate on rat alveolar and inflammatory macrophage populations.
Zeller JM; Buys CM; Gudewicz PW
Inflammation; 1984 Sep; 8(3):231-9. PubMed ID: 6490136
[TBL] [Abstract][Full Text] [Related]
2. Modulation of inflammatory peritoneal cell function and metabolism by methotrexate.
Zeller JM; Gudewicz PW
J Immunopharmacol; 1981-1982; 3(3-4):309-21. PubMed ID: 7347766
[TBL] [Abstract][Full Text] [Related]
3. Functional resistance of inflammatory macrophages to methotrexate in vitro.
Zeller JM; Gudewicz PW
J Leukoc Biol; 1984 May; 35(5):475-87. PubMed ID: 6425443
[TBL] [Abstract][Full Text] [Related]
4. The suppression of rat collagen-induced arthritis and inhibition of macrophage derived mediator release by liposomal methotrexate formulations.
Williams A; Goodfellow R; Topley N; Amos N; Williams B
Inflamm Res; 2000 Apr; 49(4):155-61. PubMed ID: 10858015
[TBL] [Abstract][Full Text] [Related]
5. The effects of cortisone treatment and burn injury on plasma and lung lavage cortisol concentrations and alveolar macrophage activity.
Gudewicz PW; Ferguson JL; Kapin MA; Jaffe RC
Adv Shock Res; 1981; 5():123-32. PubMed ID: 7304325
[TBL] [Abstract][Full Text] [Related]
6. Maintenance of the normal rat alveolar macrophage cell population. The roles of monocyte influx and alveolar macrophage proliferation in situ.
Shellito J; Esparza C; Armstrong C
Am Rev Respir Dis; 1987 Jan; 135(1):78-82. PubMed ID: 2948433
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo methotrexate disposition in alveolar macrophages: comparison of pharmacokinetic parameters of two formulations.
Doddoli C; Ghez O; Barlési F; D'journo B; Robitail S; Thomas P; Clerc T
Int J Pharm; 2005 Jun; 297(1-2):180-9. PubMed ID: 15869851
[TBL] [Abstract][Full Text] [Related]
8. Mononuclear phagocyte adherence in the presence of laminin. A possible marker of cellular differentiation.
Giavazzi R; Hart IR
Exp Cell Res; 1983 Jul; 146(2):391-9. PubMed ID: 6873196
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1beta (IL-1beta) inhibition: a possible mechanism for the anti-inflammatory potency of liposomally conjugated methotrexate formulations in arthritis.
Williams AS; Jones SG; Goodfellow RM; Amos N; Williams BD
Br J Pharmacol; 1999 Sep; 128(1):234-40. PubMed ID: 10498857
[TBL] [Abstract][Full Text] [Related]
10. Effects of polysaccharide fractions isolated from
Suszko A; Obmińska-Mrukowicz B
Indian J Med Res; 2017 Feb; 145(2):229-236. PubMed ID: 28639600
[TBL] [Abstract][Full Text] [Related]
11. Cyclophosphamide modulation of bronchoalveolar cellular populations and macrophage oxidative metabolism. Possible mechanisms of pulmonary pharmacotoxicity.
Cooper JA; Merrill WW; Reynolds HY
Am Rev Respir Dis; 1986 Jul; 134(1):108-14. PubMed ID: 3014931
[TBL] [Abstract][Full Text] [Related]
12. Suppression and recovery of the alveolar macrophage phagocytic system during continuous exposure to 0.5 ppm ozone.
Gilmour MI; Hmieleski RR; Stafford EA; Jakab GJ
Exp Lung Res; 1991; 17(3):547-58. PubMed ID: 1860453
[TBL] [Abstract][Full Text] [Related]
13. In vivo and in vitro NO2 exposures enhance phagocytic and tumoricidal activities of rat alveolar macrophages.
Sone S; Brennan LM; Creasia DA
J Toxicol Environ Health; 1983 Jan; 11(1):151-63. PubMed ID: 6827622
[TBL] [Abstract][Full Text] [Related]
14. Origin and kinetics of pulmonary macrophages during an inflammatory reaction induced by intravenous administration of heat-killed bacillus Calmette-Guérin.
Blussé van Oud Alblas A; van der Linden-Schrever B; van Furth R
J Exp Med; 1981 Aug; 154(2):235-52. PubMed ID: 7264558
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin and tumor necrosis factor secretion by peritoneal macrophages isolated from normal and arthritic rats treated with liposomal methotrexate.
Williams AS; Camilleri JP; Topley N; Williams BD
J Pharmacol Toxicol Methods; 1994 Sep; 32(1):53-8. PubMed ID: 7833508
[TBL] [Abstract][Full Text] [Related]
16. The effects of low-dose methotrexate on thymidylate synthetase activity in human peripheral blood mononuclear cells.
Hornung N; Stengaard-Pedersen K; Ehrnrooth E; Ellingsen T; Poulsen JH
Clin Exp Rheumatol; 2000; 18(6):691-8. PubMed ID: 11138330
[TBL] [Abstract][Full Text] [Related]
17. The effect of peritoneal lavage on peritoneal cellular defense mechanisms.
Abbasoglu O; Sayek I; Hascelik G
Acta Chir Belg; 1994; 94(6):321-4. PubMed ID: 7846992
[TBL] [Abstract][Full Text] [Related]
18. Leukotriene B4 production by the human alveolar macrophage: a potential mechanism for amplifying inflammation in the lung.
Martin TR; Altman LC; Albert RK; Henderson WR
Am Rev Respir Dis; 1984 Jan; 129(1):106-11. PubMed ID: 6322626
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate selectively targets human proinflammatory macrophages through a thymidylate synthase/p53 axis.
Municio C; Soler Palacios B; Estrada-Capetillo L; Benguria A; Dopazo A; García-Lorenzo E; Fernández-Arroyo S; Joven J; Miranda-Carús ME; González-Álvaro I; Puig-Kröger A
Ann Rheum Dis; 2016 Dec; 75(12):2157-2165. PubMed ID: 26920997
[TBL] [Abstract][Full Text] [Related]
20. Methotrexate suppresses nitric oxide production ex vivo in macrophages from rats with adjuvant-induced arthritis.
Omata T; Segawa Y; Inoue N; Tsuzuike N; Itokazu Y; Tamaki H
Res Exp Med (Berl); 1997; 197(2):81-90. PubMed ID: 9380953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
